Atef Israel, MD
Pain Medicine · Independence, MONPI 1700867587
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Nevro Corp. at 25.4% of the total. Reporting peaked in 2019 at $1,624 and has fallen 65.2% since, to $565 in 2025.
Across 263 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$397
- Scilex Pharmaceuticals Inc.$277
- Boston Scientific$271
- Collegium Pharmaceutical, Inc.$214
- Medtronic$198
- plus $2K from 29 others
Across 62 payments — averaging $1049.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$65K
What the payments were for
- Food & beverage$4,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 51 | $1,129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $397 |
| Scilex Pharmaceuticals Inc. | 17 | $277 |
| Boston Scientific | 16 | $271 |
| Collegium Pharmaceutical, Inc. | 13 | $214 |
| Medtronic(2 entities) | 10 | $198 |
| Biodelivery Sciences International, Inc. | 13 | $164 |
| Protega Pharmaceutials Inc | 11 | $159 |
| Globus Medical | 4 | $153 |
| Amgen(2 entities) | 9 | $145 |
| Pfizer | 18 | $138 |
| Arbor Pharmaceuticals, Inc. | 9 | $130 |
| Sentynl Therapeutics, Inc. | 10 | $125 |
| Tersera Therapeutics LLC | 6 | $121 |
| Daiichi Sankyo Inc. | 8 | $117 |
| GRT US Holding, Inc. | 4 | $82 |
| Pacira Pharmaceuticals Incorporated | 3 | $65 |
| AbbVie | 3 | $62 |
| ANI Pharmaceuticals, Inc. | 3 | $55 |
| Abbott | 3 | $40 |
| SPR Therapeutics, Inc | 2 | $39 |
| AstraZeneca | 3 | $37 |
| IBSA Pharma Inc. | 2 | $37 |
| Convatec Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Fidia Pharma USA Inc. | 1 | $33 |
| Novartis | 2 | $29 |
| Nalu Medical, Inc. | 1 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Vertex | 1 | $26 |
| Almatica Pharma LLC | 1 | $17 |
| Averitas Pharma Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Bioventus LLC | 1 | $14 |
| Electronic Waveform Lab, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$134
How this compares
$4,444 in reported general payments places this provider in the 60th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 25 | $34,374 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,090 | $25,570 |
| BelbucaBuprenorphine Hcl | 22 | $22,722 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 501 | $14,377 |
| Fentanyl | 110 | $12,928 |
| ZtlidoLidocaine | 14 | $11,131 |
| Pregabalin | 419 | $8,821 |
| Gabapentin | 618 | $7,879 |
| OxycontinOxycodone Hcl | 16 | $7,085 |
| Oxycodone Hcl | 331 | $6,189 |
| SavellaMilnacipran Hcl | 11 | $5,397 |
| Lidocaine | 50 | $5,213 |
| Tizanidine Hcl | 424 | $4,425 |
| Morphine Sulfate ErMorphine Sulfate | 120 | $3,036 |
| Baclofen | 134 | $2,874 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca | $214 | $57,09647 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $277 | $11,13114 claims |
| AbbVieSavella | $62 | $5,39711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 124 pain medicine providers in Missouri.
Other pain medicine in Independence
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
- Chad SheltonSaint Peters$18K
- Katharine GurbaSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.